Semiquantitative analysis of Th1 and Th2 cytokine expression in CD3+, CD4+, and CD8+ renal-cell-carcinoma-infiltrating lymphocytes

Cancer Immunology Immunotherapy

Volumn 48, Issue 4, 1999, Pages 204-208

  Elsässer Beile, Ursula ^a   Grussenmeyer, Thomas ^a   Gierschner, Dorothee ^a   Schmoll, Barbara ^a   Schultze Seemann, Wolfgang ^a   Wetterauer, Ulrich ^a   Schulte Mönting, Jürgen ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Renal cell carcinoma; TIL Cytokine expression

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2; MESSENGER RNA; TUMOR NECROSIS FACTOR;

ARTICLE; CARCINOMA CELL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GENE EXPRESSION; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; KIDNEY CARCINOMA; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC INFILTRATION; PRIORITY JOURNAL; PROTEIN SECRETION; QUANTITATIVE ASSAY; TUMOR ASSOCIATED LEUKOCYTE;

ANTIGENS, CD3; ANTIGENS, CD4; ANTIGENS, CD8; CARCINOMA, RENAL CELL; CYTOKINES; HUMANS; KIDNEY NEOPLASMS; LYMPHOCYTES, TUMOR-INFILTRATING; RNA, MESSENGER;

EID: 0032854201     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050566     Document Type: Article

References (28)

1. 1. Alexander JP, Kudoh S, Melsop KA, Hamilton TA, Edinger MG, Tubbs RR, Sica D, Tuason L, Klein E, Bukowski RM, Finke JH (1993) T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors. Cancer Res 53:1380
2. 2. Angevin E, Kremer F, Gaudin C, Hercend T, Triebel F (1997) Analysis of T-cell immune response in renal cell carcinoma: polarization to type 1-like differentiation pattern, clonal T-cell expansion and tumor-specific cytotoxicity. Int J Cancer 72:431
3. 3. Asselin-Paturel C, Echchakir H, Carayol G, Gay F, Opolon P, Grunenwald D, Chouaib S, Mami-Chouaib F (1998) Quantitative analysis of Th1, Th2 and TGF-beta1 cytokine expression in tumor, TIL and PBL of non-small cell lung cancer patients. Int J Cancer 77:7
4. 4. Belldegrun A, Muul LM, Rosenberg SA (1988) Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity. Cancer Res 48:206
5. 5. Belldegrun A, Kasid A, Uppenkamp M, Topalian SL, Rosenberg SA (1989) Human tumor infiltrating lymphocytes. Analysis of lymphokine mRNA expression and relevance to cancer immunotherapy. J Immunol 142:4520
6. 6. Brouwenstijn N, Gaugler B, Krüse KM, Spek CW van der, Mulder A, Osanto S, Eynde BJ van den, Schrier PI (1996) Renal-cell carcinoma-specific lysis by cytotoxic T-lymphocyte clones isolated from peripheral blood lymphocytes and tumor-infiltrating lymphocytes. Int J Cancer 68:177
7. 7. Bukowski RM, Sharfman W, Murthy S, Rayman P, Tubbs R, Alexander Budd GT, Sergi JS, Bauer L, Gibson V, et al (1991) Clinical results and characterization of tumor-infiltrating lymphocytes with or without recombinant interleukin 2 in human metastatic renal cell carcinoma. Cancer Res 51:4199
8. 8. Caignard A, Guillard M, Gaudin C, Escudier B, Triebel F, Dietrich P-Y (1996) In situ demonstreation of renal-cell-carcinoma-specific T-cell clones. Int J Cancer 66:564
9. 9. Elsässer-Beile U, Wetterauer U, Schultze-Seemann W, Gallati H, Schulte Mönting J, Kleist S von (1996) Analysis of the immune reactivity of infiltrating and peripheral lymphocytes from patients with renal cell carcinoma by measuring cytokine secretion. Cancer Immunol Immunother 42:93
10. 10. Filgueira L, Zuber M, Merlo A, Caetano V, Schultz E, Harder F, Spagnoli GC, Heberer M (1993) Cytokine gene transcription in renal cell carcinoma. Br J Surg 80:1322
11. lck in T-cells infiltrating human renal cell carcinoma. Cancer Res 53:5613
12. 12. Finke JH, Rayman P, Hart L, Alexander JP, Edinger MG, Tubbs RR, Klein E, Tuason L, Bukowski RM (1994) Characterization of tumor-infiltrating lymphocyte subsets from human renal cell carcinoma - specific reactivity defined by cytotoxicity, interferon-gamma secretion, and proliferation. J Immunother 15:91
13. 13. Gaudin C, Dietrich PY, Robache S, Guillard M, Escudier B, Lacombe MJ, Kumar A, Triebel F, Caignard A (1995) In vivo local expansion of clonal T cell subpopulations in renal cell carcinoma. Cancer Res 55:685
14. 14. Hove LE van den, Gool SW van, Poppel H van, Baert L, Coorevits L, Damme B van, Ceuppens JL (1997) Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma. Clin Exp Immunol 109:501
15. 15. Kudoh S, Stanley J, Edinger MG, Tubbs RR, Klein E, Bukowski RM, Finke JH (1994) T lymphocytes infiltrating renal cell carcinoma have a reduced expression of transferrin receptor. Int J Cancer 58:369
16. 16. Maeurer MJ, Martin DM, Castelli C, Elder E, Leder G, Storkus WJ, Lotze MT (1995) Host immune response in renal cell cancer - interleukin-4 (IL-4) and IL-10 mRNA are frequently detected in freshly collected tumor-infiltrating lymphocytes. Cancer Immunol Immunother 41:111
17. 17. Mitropoulos D, Kooi S, Rodriguez-Villanueva J, Platsoucas CD (1994) Characterization of fresh (uncultured) tumour-infiltrating lymphocytes (TIL) and TIL-derived T cell lines from patients with renal cell carcinoma. Clin Exp Immunol 97:321
18. 18. Nakagomi H, Pisa P, Pisa EK, Yamamoto Y, Halapi E, Backlin K, Juhlin C, Kiessling R (1995) Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal carcinoma. Int J Cancer 63:366
19. 19. Ng SY, Gunning P, Eddy R, Ponte P, Leavitt J, Shows T, Kedes L (1985) Evolution of the functional human β-actin gene and its multi-pseudogene family: conservation of noncoding regions and chromosomal dispersion of pseudogenes. Mol Cell Biol 5:2720
20. 20. Pierce WC, Belldegrun A, Figlin RA (1995) Cellular therapy: scientific rationale and clinical results in the treatment of metastatic renal-cell carcinoma. Semin Oncol 22:74
21. 21. Raff T, Giet M van der, Endemann D, Wiederholt T, Paul M (1997) Design and testing of beta-actin primers for RT-PCR that do not co-amplyfy processed pseudogenes. Biotechniques 23:456
22. 22. Schendel DJ, Gansbacher B, Oberneder R, Krieglmair M, Hofstetter A, Riethmüller G, Segurado OG (1993) Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines. J Immunol 151:4209
23. + T cell clones isolated from human renal cell carcinoma possess the functional characteristics of Th2 helper cells. Cell Immunol 150:114
24. 24. Tartour E, Latour S, Mathiot C, Thiounn N, Mosseri V, Joyeux I, Dubois D'Enghien C, Lee R, Debre B, Herman Fridman W (1995) Variable expression of CD3-ζ chain in tumor-infiltrating lymphocytes (TIL) derived from renal-cell carcinoma: relationship with TIL phenotype and function. Int J Cancer 63:205
25. 25. Tureci O, Sahin U, Vollmar E, Siemer S, Gottert E, Seitz G, Parkkila AK, Shah GN, Grubb JH, Pfreundschuh M, Sly WS (1998) Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers. Proc Natl Acad Sci USA 95:7608
26. 26. Wang Q, Redovan C, Tubbs R, Olencki T, Klein E, Kudoh S, Finke J, Bukowski RM (1995) Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor-infiltrating lymphocytes. Int J Cancer 61:780
27. 27. Whiteside TL, Parmiani G (1994) Tumor-infiltrating lymphocytes: their phenotype, functions and clinical use. Cancer Immunol Immunother 39:15
28. 28. Whiteside TL, Miescher S, Hurlimann J, Moretta L, Fliedner V von (1986) Separation, phenotyping and limiting dilution analysis of T-lymphocytes infiltrating human solid tumors. Int J Cancer 37:803